Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061529) titled 'A retrospective survey of FLEND therapy for relapsed or refractory T-cell acute lymphoblastic leukemia' on May 12.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - Relapsed and refractory T-cell acute lymphoblastic leukemia
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to retrospectively investigate the re-induction complete remission rate and adverse events of FLEND therapy (a combination chemotherapy of fludarabine, etoposide, and nelarabine) in pediatric and...